Carboxymethylated Poria cocos Polysaccharides Mitigate Cisplatin‐Induced Hepatorenal Injury by Activating the PLC‐PKC‐Nrf2 Signaling Pathway
The findings suggest that CMP has the potential to serve as an adjunctive agent in cisplatin chemotherapy to protect the kidneys and liver from damage.